Avenue Therapeutics Inc.

(NASDAQ:ATXI) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Avenue Therapeutics Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of postoperative pain.

Contact Information

Website: www.avenuetx.com
Email: jeremy@lifesciadvisors.com
Main Phone: +1 781 652-4500
Address: 1140 Avenue of the Americas
Address 2: 9th Floor
State: NY
City / Town: New York
Country: US
Postal Code: 10036

Issuer Information

Exchange: NSC
CEO: Lucy Lu
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A